Nova Chemics xtc Pills – 200 mg Pure MDMA Ecstasy Tablets

Transform your PTSD, empathy, and serotonin research with Nova Chemics Ecstasy Tablets—clinically aligned 200 mg MDMA HCl pills, engineered for labs replicating FDA-approved therapy protocols, social neuroscience, or neuropharmacology studies. Each tablet contains 99.5%+ pure S-MDMA, validated by HPLC, GC-MS, NMR, and USP dissolution, with zero adulterants, no caffeine, no dyes, no fentanyl risk. Perfect for fear extinction modeling, 5-HT2A activation, or controlled clinical simulation—delivering consistent release, predictable pharmacokinetics, and peer-reviewed reliability.

Produced in ISO 7 cleanrooms using pharmaceutical-grade excipients, these 8 mm white, scored tablets (300 mg total) dissolve >90% in 15 minutes. Research onset: 30–45 min (oral), peak at 90–150 min, effects last 4–6 hours—ideal for therapeutic dosing, oxytocin studies, or neuroprotection trials. As MDMA-assisted therapy nears full approval in 2025, our tablets match MAPS/Lykos clinical standards—S-isomer only, no racemic mix, no impurities.

Understanding Ecstasy Tablets: The Science of Healing Connection

Ecstasy (XTC pills) refers to oral MDMA tablets, historically 80–120 mg in recreational use, now standardized at 200 mg in clinical settings for PTSD, depression, and social anxiety. MDMA triggers massive serotonin release, oxytocin surge, and amygdala downregulation—enabling emotional processing without overwhelm. Our tablets use pure S-MDMA HCl (the active, therapeutic enantiomer), free from R-MDMA, MDA, or synthetic cathinones. Unlike street pills (often <60% MDMA), Nova Chemics delivers lab-pure, trial-ready tablets—same formulation used in FDA Breakthrough Therapy trials.

Core Advantages: Built for Clinical Precision

• 200 mg Exact Dose: Matches MAPS Phase III protocol
• Scored for Fractioning: Split into 50 mg quarters
• Pharma-Grade Fillers: MCC, magnesium stearate, silica—all USP
• Rapid Breakdown: Full dissolution in 15 min
• Chiral Purity: 99.9%+ S-MDMA

Why trust Nova Chemics? We synthesize, purify, and press every tablet in-house—no third-party sourcing. Each batch undergoes full USP compliance testing, ensuring zero variability—the same reliability powering global clinical research.

Technical Specifications

Download COA → NC-XTC-2025-11F Lab Report

Color Test Reactions

Included: 6-test reagent kit, fentanyl strips, pill crusher

Research Dosing & Administration Guide

1. Preparation:
   • Full tablet = 200 mg
   • Quarter = 50 mg (use score line)
   • Crush + dissolve in saline for gavage
2. Model Dosing:
   • Therapy Simulation: 1.5–3 mg/kg IP
   • Neurotoxicity: 15–20 mg/kg
3. Delivery:
   • Oral gavage → clinical relevance
   • IP injection → faster onset
4. Monitoring: Temperature, behavior, serotonin levels

Packaging & Stability

• Container: HDPE bottle (30/100 pills), child-resistant cap, desiccant
• Outer: Vacuum mylar + plain box (“dietary supplement”)
• Storage:
  • Room temp: 36+ months
  • Refrigerated: 48+ months
  • Opened: Use within 6 months

Safety Protocols

Risks include hyperthermia, jaw clenching, serotonin depletion. Avoid with SSRIs/MAOIs. LD₅₀ (rat): ~300 mg/kg. Use fume hood, gloves, goggles. Includes cooling guidelines and emergency response card.

Delivery & Discretion

• From: EU & US warehouses
• Arrival: EU/UK 1–3 days, US/CA 2–4 days, Global 4–7 days
• Guarantee: 100% reship if intercepted
• Free shipping over €200

Secure Purchase Process

1. Choose pack size → Add to cart
2. Pay with Crypto (10% off)
3. Shipped within 24 hours

Wholesale: 1,000+ pills = bulk pricing + priority

Support & Guarantees

• 24/7 Help (@NovaSupport24 on Telegram)
• Replacement – Free if dose inaccurate
• Authenticity – Full refund if COA fails
• Consultation – Free trial design support
• Resolution – Fixed in under 12 hours

Regulatory Compliance

DEA Schedule I | Class A (UK) | Schedule I (CA) Research-only with DEA license & import approval Buyer confirms institutional use and legal compliance